Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

(R)-8-(1-((3-fluorophenyl)amino)ethyl)-N-(2-hydroxyethyl)-2-morpholinoquinoxaline-6-carboxamide for inhibiting phosphoinositide-3-kinase activity

US Patent 11267804 · Granted Mar 8, 2022

Estimated economic value: $372,209,000

Assignee

Inventors

View full patent text on Google Patents →